Log in

Institute for Molecular Regenerative Medicine

We are studying the cellular and molecular regeneration processes of the ill brain and develop new pharmacological applications on this basis for development of medicaments for the treatment ofdementia, Parkinson disease, amyotrophic lateral sclerosis, as well as spinal paralysis. In previous studies, we could actually rejuvenate structurally and functionally the brain suffering from dementia to such an extent that the learning and memory capacities could be completely restored.


The objective of the research work is the restoration of the functions which have been lost as a result of traumas or diseases of the central nervous system. In particular, the restoration of the motor and sensoric functions after an injury of the spinal cord.

© 2021 Austrian Neuroscience Association (ANA) / Österreichische Gesellschaft für Neurowissenschaften (ÖGN)